| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 59WCJ0YNWM |
| InChI Key | YBAWYTYNMZWMMJ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H19F5N2O |
| Molecular Weight | 398.38 |
| AlogP | 4.92 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 37.05 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Primary Target | |
|---|---|
| 5-HT6 receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 6 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
- | - | - | 1215 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | 1000 | - | 1-7 | 88-106 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 467459-31-0 |
| ChEMBL | CHEMBL3286580 |
| DrugBank | DB11957 |
| FDA SRS | 59WCJ0YNWM |
| Guide to Pharmacology | 8689 |
| PubChem | 21071390 |
| SureChEMBL | SCHEMBL762762 |
| ZINC | ZINC000095936819 |